Naka T, Fukuda T, Shinohara N, Iwamoto Y, Sugioka Y, Tsuneyoshi M
Second Department of Pathology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Cancer. 1995 Sep 15;76(6):972-84. doi: 10.1002/1097-0142(19950915)76:6<972::aid-cncr2820760610>3.0.co;2-t.
It is often difficult to discriminate between osteosarcoma and malignant fibrous histiocytoma (MFH) of bone, especially in older patients because of the clinical similarities, including the lytic radiologic appearance. A histologic analysis of MFH-like osteosarcoma, which closely resembles MFH of bone both clinically and radiologically, has not yet been conducted thoroughly, and therefore this issue remains controversial.
Using clinicopathologic and immunohistochemical techniques, the authors studied 24 cases of osteosarcoma arising in patients older than 40 years of age and compared them with 20 cases of MFH of bone from similarly aged patients.
Radiography revealed that 68.2% of the osteosarcoma cases were predominantly lytic, whereas all cases of MFH of bone showed either a predominantly or purely lytic pattern. Histologically, osteosarcoma was subclassified as conventional osteoblastic (54.2%), MFH-like (29.2%) containing various amounts of tumor osteoid and/or bone in each of the cases, and conventional fibroblastic (4.2%), whereas all the cases of MFH of bone had a storiform-pleomorphic pattern. Immunohistochemically, no overexpression of p53 protein was found in MFH-like osteosarcoma, whereas it tended to occur more frequently in osteoblastic osteosarcoma (66.7%) and MFH of bone (50.0%). The Ki-67 labeling index was significantly lower in MFH-like osteosarcoma than in MFH of bone. The 5-year survival rate was 18.2% in patients with osteoblastic osteosarcoma, 66.7% in patients with MFH-like osteosarcoma, and 21.5% in patients with MFH of bone. A significant difference in the survival curve was observed between osteoblastic and MFH-like osteosarcoma.
It is proposed that MFH-like osteosarcoma, which shows characteristically different clinical and histologic features from that of conventional osteosarcoma, thus may be considered a variant of osteosarcoma.
骨肉瘤与骨恶性纤维组织细胞瘤(MFH)的鉴别诊断往往存在困难,尤其是在老年患者中,因为二者在临床上有相似之处,包括影像学上的溶骨性表现。对于临床和影像学上与骨MFH极为相似的MFH样骨肉瘤,尚未进行全面的组织学分析,因此这一问题仍存在争议。
作者运用临床病理和免疫组化技术,研究了24例年龄大于40岁患者的骨肉瘤病例,并与20例同龄患者的骨MFH病例进行比较。
影像学检查显示,68.2%的骨肉瘤病例主要为溶骨性,而所有骨MFH病例均表现为主要或单纯溶骨模式。组织学上,骨肉瘤分为传统成骨型(54.2%)、MFH样(29.2%),各病例中均含有不同量的肿瘤类骨质和/或骨,以及传统纤维母细胞型(4.2%),而所有骨MFH病例均为席纹状-多形性模式。免疫组化显示,MFH样骨肉瘤中未发现p53蛋白过表达,而成骨型骨肉瘤(66.7%)和骨MFH(50.0%)中p53蛋白过表达更常见。MFH样骨肉瘤的Ki-67标记指数显著低于骨MFH。成骨型骨肉瘤患者的5年生存率为18.2%,MFH样骨肉瘤患者为66.7%,骨MFH患者为21.5%。成骨型和MFH样骨肉瘤的生存曲线存在显著差异。
MFH样骨肉瘤与传统骨肉瘤在临床和组织学特征上有显著差异,因此可被视为骨肉瘤的一种变异型。